The inflammation process in large vessels involves the up-regulation of vascular adhesion molecules such as endothelial cell selectin (E-selectin), intercellular cell adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) which are also known as the markers of atherosclerosis. We have reported that Chlorella 11-peptide exhibited effective anti-inflammatory effects. This peptide with an amino sequence Val-Glu-Cys-Tyr-Gly-Pro-Asn-Arg-Pro-Gln-Phe was further examined for its potential in preventing atherosclerosis in this study. In particular, the roles of Chlorella 11-peptide in lowering the production of vascular adhesion molecules, monocyte chemoattractant protein (MCP-1) and expression of endothelin-1 (ET-1) from endothelia (SVEC4-10 cells) were studied. The production of E-selectin, ICAM-1, VCAM-1 and MCP-1 in SVEC4-10 cells was measured with ELISA. The mRNA expression of ET-1 was analyzed by RT-PCR and agarose gel. Results showed that Chlorella 11-peptide significantly suppressed the levels of E-selectin, ICAM, VCAM, MCP-1 as well as ET-1 gene expression. The inhibition of ICAM-1 and VCAM-1 production by Chlorella 11-peptide was reversed in the presence of protein kinase A inhibitor (H89) which suggests that the cAMP pathway was involved in the inhibitory cause of the peptide. In addition, this peptide was shown to reduce the extent of increased intercellular permeability induced by combination of 50% of lipopolysaccharide (LPS)-activated RAW 264.7 cells medium and 50% normal SEVC cell culture medium (referred to as 50% RAW-conditioned medium). These data demonstrate that Chlorella 11-peptide is a promising biomolecule in preventing chronic inflammatory-related vascular diseases.
References
[1]
Kacimi, R.; Karliner, J.S.; Koudssi, F.; Long, C.S. Expression and regulation of adhesion molecules in cardiac cells by cytokines response to acute hypoxia. Circ. Res. 1998, 82, 576–586, doi:10.1161/01.RES.82.5.576.
[2]
Blankenberg, S.; Barbaux, S.; Tiret, L. Adhesion molecules and atherosclerosis. Atherosclerosis 2003, 170, 191–203, doi:10.1016/S0021-9150(03)00097-2.
[3]
Ridker, P.M.; Buring, J.E.; Rifai, N. Soluble P-selectin and the risk of future cardiovascular events. Circulation 2001, 103, 491–495, doi:10.1161/01.CIR.103.4.491.
[4]
Nasuno, A.; Matsubara, T.; Hori, T.; Higuchi, K.; Imai, S.; Nakagawa, I.; Tsuchida, K.; Ozaki, K.; Mezaki, T.; Tanaka, T.; et al. Levels of soluble E-selectin and ICAM-1 in the coronary circulation of patients with stable coronary artery disease: Association with the severity of coronary atherosclerosis. Jpn. Heart. J. 2002, 43, 93–101, doi:10.1536/jhj.43.93.
[5]
Blake, G.J.; Ridker, P.M. Inflammatory bio-markers and cardiovascular risk prediction. J. Int. Med. 2002, 252, 283–294, doi:10.1046/j.1365-2796.2002.01019.x.
[6]
Tardif, J.C.; Grégoire, J.; Lavoie, M.A.; L’Allier, P.L. Vascular protectants for the treatment of atherosclerosis. Expert. Rev. Cardiovasc. 2003, 1, 385–392, doi:10.1586/14779072.1.3.385.
[7]
Wilcox, J.N.; Nelken, N.A.; Coughlin, S.R.; Gordon, D.; Schall, T.J. Local expression of inflammatory cytokines in human atherosclerotic plaques. J. Atheroscler. Thromb. 1994, 1, S10–S13.
[8]
Gown, A.M.; Tsukada, T.; Ross, R. Human atherosclerosis: II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am. J. Pathol. 1986, 125, 191–207.
[9]
Deo, R.; Khera, A.; McGuire, D.K.; Murphy, S.A.; Meo Neto, J.P.; Morrow, D.A.; de Lemos, J.A. Association among plasma levels of monocyte chemoattractant protein-1, traditional cardiovascular risk factors, and subclinical atherosclerosis. J. Am. Coll. Cardiol. 2004, 44, 1792–1800.
[10]
Sheikine, Y.; Hansson, G.K. Chemokines and atherosclerosis. Ann. Med. 2004, 36, 98–118, doi:10.1080/07853890310019961.
[11]
Hayashidani, S.; Tsutsui, H.; Shiomi, T.; Ikeuchi, M.; Matsusaka, H.; Suematsu, N.; Wen, J.; Egashira, K.; Takeshita, A. Anti-monocyte chemoattractant protein-1 gene therapy attenuates left ventricular remodeling and failure after experimental myocardial infarction. Circulation 2003, 108, 1–7, doi:10.1161/01.CIR.0000069947.13421.2E.
Martinovic, I.; Abegunewardene, N.; Seul, M.; Vosseler, M.; Horstick, G.; Buerke, M.; Darius, H.; Lindemann, S. Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease. Circ. J. 2005, 69, 1484–1489, doi:10.1253/circj.69.1484.
[14]
Inoue, S.; Egashira, K.; Ni, W.; Kitamoto, S.; Usui, M.; Otani, K.; Ishibashi, M.; Hiasa, K.; Nishida, K.; Takeshita, A. Anti-monocyte chemoattractant protein-1 gene therapy limits progression and destabilization of established atherosclerosis in apolipoprotein E-knockout mice. Circulation 2002, 106, 2700–2706, doi:10.1161/01.CIR.0000038140.80105.AD.
[15]
Little, P.J.; Ivey, M.E.; Osman, N. Endothelin-1 actions on vascular smooth muscle cell functions as a target for the prevention of atherosclerosis. Curr. Vasc. Pharmacol. 2008, 6, 195–203, doi:10.2174/157016108784911966.
[16]
Winkles, J.A.; Alberts, G.F.; Brogi, E.; Libby, P. Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries. Biochem. Biophys. Res. Commun. 1993, 191, 1081–1088, doi:10.1006/bbrc.1993.1327.
[17]
Cherng, J.-Y.; Shih, M.-F. Preventing dyslipidemia by Chlorella pyrenoidosa in rats and hamsters after chronic high fat diet treatment. Life Sci. 2005, 76, 3001–3013, doi:10.1016/j.lfs.2004.10.055.
[18]
Sano, T.; Tanaka, Y. Effects of dried powdered Chlorella vulgaris on experimental atherosclerosis and alimentary hypercholesterolemia in cholesterol-fed rabbit. Artery 1987, 14, 76–84.
[19]
Cherng, J.Y.; Liu, C.C.; Shen, C.R.; Lin, H.H.; Shih, M.-F. Beneficial effects of Chlorella-11 peptide on blocking the LPS-induced macrophage activation and alleviating the thermal injury induced inflammation in rats. Int. J. Immunopathol. Pharmacol. 2010, 24, 817–826.
[20]
Sheih, I.C.; Fang, T.J.; Wu, T.K.; Lin, P.H. Anticancer and antioxidant activities of the peptide fraction from algae protein waste. J. Agric. Food Chem. 2010, 58, 1202–1207, doi:10.1021/jf903089m.
[21]
Ross, R. Atherosclerosis is an inflammatory disease. Am. Heart. J. 1999, 138, S419–S420, doi:10.1016/S0002-8703(99)70266-8.
[22]
Rus, H.G.; Vlaicu, R.; Niculescu, F. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis 1996, 127, 263–271, doi:10.1016/S0021-9150(96)05968-0.
[23]
Harama, D.; Koyama, K.; Mukai, M.; Shimokawa, N.; Miyata, M.; Nakamura, Y.; Ohnuma, Y.; Ogawa, H.; Matsuoka, S.; Paton, A.W.; et al. A subcytotoxic dose of subtilase cytotoxin prevents lipopolysaccharide-induced inflammatory responses, depending on its capacity to induce the unfolded protein response. J. Immunol. 2009, 183, 1368–1374, doi:10.4049/jimmunol.0804066.
[24]
Krieglstein, C.F.; Granger, D.N. Adhesion molecules and their role in vascular disease. Am. J. Hypertens. 2001, 14, S44–S54, doi:10.1016/S0895-7061(01)02069-6.
[25]
Granger, D.N.; Vowinkel, T.; Petnehazy, T. Modulation of the inflammatory response in cardiovascular disease. Hypertension 2004, 43, 924–931, doi:10.1161/01.HYP.0000123070.31763.55.
[26]
Amberger, A.; Hala, M.; Saurwein-Teissl, M.; Metzler, B.; Grubeck-Loebenstein, B.; Xu, Q.; Wick, G. Suppressive effects of anti-inflammatory agents on human endothelial cell activation and induction of heat shock proteins. Mol. Med. 1999, 5, 117–128.
[27]
Fotis, L.; Giannakopoulos, D.; Stamogiannou, L.; Xatzipsalti, M. Intercellular cell adhesion molecule-1 and vascular cell adhesion molecule-1 in children. Do they play a role in the progression of atherosclerosis? Hormones (Athens) 2012, 11, 140–146.
[28]
Poston, R.N.; Johnson-Tidey, R.R. Localized adhesion of monocytes to human atherosclerotic plaques demonstrated in vitro: Implications for atherogenesis. Am. J. Pathol. 1996, 149, 73–80.
[29]
Ghersa, P.; Hooft van Huijs duijnen, R.; Whelan, J.; Cambet, Y.; Pescini, R.; DeLamarter, J.F. Inhibition of E-selectin gene transcription through a cAMP-dependent protein kinase pathway. J. Biol. Chem. 1994, 269, 29129–29137.
[30]
Balyasnikova, I.V.; Pelligrino, D.A.; Greenwood, J.; Adamson, P.; Dragon, S.; Raza, H.; Galea, E. Cyclic adenosine monophosphate regulates the expression of the intercellular adhesion molecule and the inducible nitric oxide synthase in brain endothelial cells. J. Cereb. Blood. Flow. Metab. 2000, 20, 688–699.
Goueli, S.A.; Ahmed, K. Indomethacin and inhibition of protein kinase reactions. Nature 1980, 287, 171–172, doi:10.1038/287171a0.
[33]
Babaei, S.; Picard, P.; Ravandi, A.; Monge, J.C.; Lee, T.C.; Cernacek, P.; Stewart, D.J. Blockade of endothelin receptors markedly reduces atherosclerosis in LDL receptor deficient mice: Role of endothelin in macrophage foam cell formation. Cardiovasc. Res. 2000, 48, 158–167, doi:10.1016/S0008-6363(00)00169-3.
[34]
Dejana, E.; Orsenigo, F.; Lampugnani, M.G. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J. Cell Sci. 2008, 121, 2115–2122, doi:10.1242/jcs.017897.
Sun, C.; Wu, M.H.; Yuan, S.Y. Nonmuscle myosin light-chain kinase deficiency attenuates atherosclerosis in apolipoprotein E-deficient mice via reduced endothelial barrier dysfunction and monocyte migration. Circulation 2011, 124, 48–57, doi:10.1161/CIRCULATIONAHA.110.988915.
[37]
O’Connell, K.A.; Edidin, M. A mouse lymphoid endothelial cell line immortalized by simian virus 40 binds lymphocytes and retains functional. J. Immunol. 1990, 144, 521–525.
[38]
Bian, C.; Wu, Y.; Chen, P. Telmisartan increases the permeability of endothelial cells through zonula occludens-1. Biol. Pharm. Bull. 2009, 32, 416–420, doi:10.1248/bpb.32.416.
